LOTUSEYE — Lotus Eye Hospital and Institute Cashflow Statement
0.000.00%
- IN₹1.64bn
- IN₹1.63bn
- IN₹482.10m
- 51
- 11
- 73
- 41
Annual cashflow statement for Lotus Eye Hospital and Institute, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 21.5 | 19.1 | 41 | 56.5 | 40.1 |
Depreciation | |||||
Non-Cash Items | -8.3 | -5.41 | -6.19 | -7.96 | -8.4 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 10 | -9.61 | -15.9 | -34.5 | -12.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 48.1 | 27.4 | 43.9 | 43.9 | 56.8 |
Capital Expenditures | -24.2 | -4.76 | -46.8 | -31 | -56.4 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 18.9 | 9.61 | 7.67 | 9.03 | 10.1 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5.25 | 4.86 | -39.2 | -21.9 | -46.3 |
Financing Cash Flow Items | -0.705 | -0.649 | -1.28 | -0.976 | -0.974 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.35 | -3.28 | -15.8 | -17.1 | -34 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 44.2 | 29 | -11 | 4.88 | -23.5 |